Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
07/19/2024 | CALL | $2.50 | 259 | +245 | +1,750.00% |
06/21/2024 | CALL | $2.50 | 21 | +21 | |
05/17/2024 | CALL | $2.50 | 25 | +20 | +400.00% |
10/18/2024 | CALL | $5.00 | 10 | +5 | +100.00% |
05/17/2024 | CALL | $5.00 | 0 | 0 | |
05/17/2024 | CALL | $7.50 | 0 | 0 | |
07/19/2024 | PUT | $7.50 | 0 | 0 | |
10/18/2024 | CALL | $2.50 | 2 | 0 | |
10/18/2024 | CALL | $7.50 | 0 | 0 | |
10/18/2024 | PUT | $2.50 | 0 | 0 | |
10/18/2024 | PUT | $5.00 | 0 | 0 | |
10/18/2024 | PUT | $7.50 | 0 | 0 |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 0.02% | 590.9k | 1.65M |
Fidelity Extended Market Index Fund | 0.00% | 82.38k | 230.67k |
Price (T.Rowe) U.S. Equities Trust | 0.00% | 29.9k | 83.72k |
Fidelity NASDAQ Composite Index Fund | 0.00% | 26.21k | 73.39k |
Fidelity Series Total Market Index Fund | 0.00% | 23.2k | 64.96k |
Fidelity Total Market Index Fund | 0.00% | 21.43k | 60k |
Schwab Capital Trust-Total Stock Market Index Fund | 0.00% | 17.22k | 48.21k |
Dimensional ETF Tr-Dimensional U.S. Core Equity 2 ETF | 0.00% | 11.51k | 32.22k |
iShares Micro Cap ETF | 0.00% | 9.13k | 25.55k |
Vanguard Extended Market Index Fund | 0.00% | 52.08k | 145.82k |
Wall Street Breakfast: What Moved Markets
08/14 08:03 am
Seeking Alpha
Read moreThe Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
08/13 07:43 am
Benzinga
Read moreThe Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
08/12 08:09 am
Benzinga
Read more